What are the treatment protocols for dengue patients in both inpatient (IPD) and outpatient (OPD) departments?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dengue Treatment: IPD and OPD Protocols

Outpatient (OPD) Management

For dengue patients without warning signs, manage with oral rehydration, acetaminophen for fever/pain, and daily monitoring—hospitalization is not required unless warning signs develop. 1

Patient Selection for OPD

  • Patients with dengue fever without warning signs can be safely managed as outpatients 1
  • Warning signs requiring hospitalization include: severe abdominal pain, persistent vomiting, clinical fluid accumulation (ascites/pleural effusion), mucosal bleeding, lethargy or restlessness, liver enlargement >2 cm, and rising hematocrit with rapidly falling platelet count 1, 2

OPD Treatment Protocol

  • Hydration strategy: Encourage 5 or more glasses of fluid throughout the day, targeting approximately 2,500-3,000 mL daily 1
  • Use any locally available fluids including water, oral rehydration solutions, cereal-based gruels, soup, and rice water—avoid soft drinks due to high osmolality 1
  • Pain and fever management: Use acetaminophen (paracetamol) only—strictly avoid aspirin and NSAIDs due to increased bleeding risk 1, 2
  • Resume age-appropriate diet as soon as appetite returns 1

OPD Monitoring Requirements

  • Daily complete blood count to track platelet counts and hematocrit levels 1
  • Critical phase awareness: Days 3-7 of illness represent the highest risk period when plasma leakage can rapidly progress to shock 1, 2
  • Educate patients to return immediately if warning signs develop 1

Inpatient (IPD) Management

For dengue with warning signs or severe dengue, admit for IV fluid management with isotonic crystalloids as first-line therapy, escalating to colloids and vasopressors only if shock persists despite adequate crystalloid resuscitation. 1

Indications for Hospitalization

  • Dengue with warning signs (listed above) 1
  • Severe dengue: dengue shock syndrome, severe bleeding, or organ impairment 1
  • Mortality rate is 1-5% without proper management but can be reduced to <0.5% with appropriate clinical care 1

IPD Fluid Management Algorithm

For Dengue with Warning Signs (No Shock)

  • Avoid routine bolus IV fluids in patients NOT in shock—this increases risk of fluid overload and respiratory complications without improving outcomes 1
  • Provide maintenance IV fluids if oral intake is inadequate 1
  • Monitor closely for progression to shock 1

For Dengue Shock Syndrome (Hypotension/Poor Perfusion)

Initial resuscitation:

  • Administer 20 mL/kg of isotonic crystalloid (Ringer's lactate or 0.9% normal saline) as rapid bolus over 5-10 minutes 1, 3
  • Reassess after each bolus for signs of improvement: improved tachycardia, tachypnea, capillary refill, mental status, and urine output 1
  • If shock persists, repeat crystalloid boluses up to total of 40-60 mL/kg in the first hour before escalating therapy 1, 3

Escalation to colloids:

  • If shock persists despite adequate crystalloid resuscitation (40-60 mL/kg), switch to colloid solutions 1, 4
  • Moderate-quality evidence shows colloids achieve faster resolution of shock (RR 1.09,95% CI 1.00-1.19) and require less total volume (mean 31.7 mL/kg versus 40.63 mL/kg for crystalloids) 1, 3
  • Options include dextran, gelafundin, or albumin 1

Vasopressor therapy for refractory shock:

  • For cold shock with hypotension: titrate epinephrine as first-line vasopressor 1, 3
  • For warm shock with hypotension: titrate norepinephrine as first-line vasopressor 1, 3
  • Begin peripheral inotropic support immediately if central venous access is not readily available—delays in vasopressor therapy are associated with major increases in mortality 1
  • Target mean arterial pressure appropriate for age and maintain ScvO2 >70% 1, 3

IPD Monitoring Parameters

  • Perfusion indicators: Normal capillary refill time, absence of skin mottling, warm and dry extremities, well-felt peripheral pulses, return to baseline mental status, and adequate urine output 1, 2
  • Daily complete blood count to track hematocrit and platelet trends 1, 2
  • Signs of fluid overload: Hepatomegaly, rales on lung examination, or respiratory distress—stop fluid resuscitation immediately if these develop and switch to inotropic support 1, 3

Management of Complications

  • Severe bleeding: Blood transfusion may be necessary 1, 2
  • Pulmonary edema: Avoid overhydration, particularly during the recovery phase 1
  • Polyserositis (pleural effusion/ascites): Avoid drainage as it can lead to severe hemorrhage and sudden circulatory collapse 5
  • Secondary hemophagocytic lymphohistiocytosis: Consider steroids or intravenous immunoglobulin if this potentially fatal complication is recognized 6

Critical Pitfalls to Avoid in IPD

  • Do not delay fluid resuscitation in established dengue shock syndrome—once hypotension occurs, cardiovascular collapse may rapidly follow 1
  • Do not use restrictive fluid strategies in dengue shock syndrome—moderate-quality evidence shows no survival benefit and may worsen outcomes 1, 3
  • Do not continue aggressive fluid resuscitation once signs of fluid overload appear—switch to inotropic support instead 1, 3
  • Do not give routine bolus IV fluids to patients with severe febrile illness who are NOT in shock 1, 2
  • Do not fail to recognize the critical phase (days 3-7) when plasma leakage can rapidly progress to shock 1, 2

References

Guideline

Dengue Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Dengue Ascites

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hypernatremia in Dengue Shock Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

FLUID AND HEMODYNAMIC MANAGEMENT IN SEVERE DENGUE.

The Southeast Asian journal of tropical medicine and public health, 2015

Research

Management of dengue fever in ICU.

Indian journal of pediatrics, 2001

Research

Management of Dengue: An Updated Review.

Indian journal of pediatrics, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.